continuous FNB
Otherfemoral nerve block (ropivacaine 0.5%, 20 mL) with femoral nerve block infusion 48 h (ropivacaine 0.2%, 5mL/h), placebo local infiltration
NCT Number: NCT01616836
The aim of this study is to determine the best method of pain control that will help with rehabilitation after total knee arthroplasty (TKA). Currently, the best method for pain control after TKA appears to be continuous femoral nerve block (FNB) where a small tube is placed beside the nerve that provides sensation to a large part of the knee and local anesthetic infused after surgery causing numbness to the surgical site. A single injection method also exists and may provide similar benefits. Both methods require training and can result in side effects such as temporary weakness (while the local anesthetic is still working) that can inhibit rehabilitation. A newer method injecting local anesthetic into the joint after surgery (Local Infiltration Analgesia (LIA)) is becoming common, does not cause weakness and can be done quickly at the end of surgery. It is unknown if the pain control provided by LIA is as good as that of FNB. This study will compare the femoral nerve block, continuous femoral nerve block and LIA technique to determine which provides better pain relief after TKA.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Phase 3
St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada
This will be a prospective, randomized, double blind study. Patients will be randomized using a computer-generated sequence to one of three groups:
Group 1: Continuous femoral nerve block group (cFNB) Group 2: Single injection femoral nerve block group (sFNB) Group 3: Local infiltration analgesia group (LIA)
Inclusion criteria
Patients between the ages of 18 and 85 having primary tri-compartmental total knee arthroplasty.
Exclusion criteria
Allergy, intolerance, or contraindication to any study medication (see below), inability to walk independently prior to TKA, inability to comprehend French or English, use of major tranquilizers, ASA 4 or 5, BMI > 40, opioid tolerance (opioid consumption > 30mg oral morphine or equivalent per day), pregnancy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
femoral nerve block (ropivacaine 0.5%, 20 mL) with femoral nerve block infusion 48 h (ropivacaine 0.2%, 5mL/h), placebo local infiltration
single femoral nerve block (ropivacaine 0.5%, 20 mL), placebo femoral nerve block infusion, placebo local infiltration
placebo fascia iliac block, placebo fascia iliaca infusion, local infiltration analgesia (tricompartmental injection of 150 mL ropivacaine 0.2%, ketorolac 30 mg, epinephrine 10 microg/mL)
Time frame: 09h00 on postoperative day 2
Pain at this time is the primary impediment to beginning physiotherapy and achieving discharge criteria
Time frame: Cumulative 4 day consumption
Opioid consumption is a surrogate outcome for pain. A reduction in opioid consumption also confers benefits of reduced side effects - nausea, dizziness, sedation, respiratory depression
Time frame: Measured each postoperative day (4 day maximum) during daily physiotherapy session
Active and passive range of motion - physical outcome measure
Time frame: Measured once at the first postoperative visit with the surgeon, 6 weeks postoperative
Validated functional outcome measure after total knee arthoplasty
Time frame: Measured once on postoperative day 2 during the physiotherapy session
Functional outcome measure
Time frame: Baseline questionnaire given preoperatively, at first postoperative visit (6 weeks), and second postoperative visit (3 months)
Western Ontario and McMaster University Osteoarthritis Index - functional outcome measure questionnaire
Time frame: Baseline questionnaire given preoperatively, at first postoperative visit (6 weeks), and second postoperative visit (3 months)
Lower extremity functional scale - functional outcome questionnaire
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 days
weakness in quadriceps from femoral nerve block can delay physiotherapy and cause falls
Time frame: From date of randomization until the first postoperative visit at 6 weeks
hematoma, infection, persistent neurological deficit 6 weeks postoperatively
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 days
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 days
Time frame: The highest NRS will be assessed daily during the patient's physiotherapy session, as well as the highest NRS achieved at 2 weeks, 6 weeks, and 3 months postoperatively
Assessing worst pain during physiotherapy, later dates to assess for the incidence of chronic pain
Sunnybrook Health Sciences Centre
Other
Optimizing Pain and Rehabilitation After Knee Arthroplasty - Randomized, Blinded Clinical Trial Comparing Continuous Femoral Nerve Block Versus Single Injection Femoral Nerve Block Versus Local Infiltration Analgesia
Acronym: OPRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07705971
Arthritis, Joint Diseases
Denizli, Turkey (Türkiye)
View Trial DetailsNCT04748549
Total Knee Arthroplasty
Boston, Massachusetts, United States
View Trial DetailsNCT06988033
Bone Diseases, Bone Diseases, Metabolic
Istanbul, Uskudar, Turkey (Türkiye)
View Trial DetailsNCT05107414
Total Knee Arthroplasty
Knoxville, Tennessee, United States
View Trial Details